Erkut Borazanci

HonorHealth — United States

Medicine · Health Sciences

27h-index4.3kcitations318works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(159), Cancer Genomics and Diagnostics(64), Epigenetics and DNA Methylation(50), Cancer Immunotherapy and Biomarkers(41), Neuroendocrine Tumor Research Advances(37)

Publications318 total

Phase II Trial of Vemurafenib and Sorafenib Combination in Advanced KRAS-Mutated Metastatic Pancreatic Cancer
Journal of Immunotherapy and Precision Oncology·2026Open Access
A phase 2 study to investigate the efficacy and safety of acoustic cluster therapy with modified FOLFIRINOX in patients with locally advanced pancreatic cancer.
Journal of Clinical Oncology·2026
Performance of a blood-biomarker test for early detection of pancreatic ductal adenocarcinoma (PDAC) across all stages of disease versus a mixed control population.
Journal of Clinical Oncology·2026
Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods
npj Precision Oncology·2025Open Access
Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Current Oncology·2025· 1 citedOpen Access
Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma
Gastroenterology·2025· 5 citedOpen Access
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer
Redox Biology·2025Open Access
Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detection (PRECEDE) Consortium
JCO Precision Oncology·2025
S5 High Performance of a Blood-Based Biomarker Test to Detect Early-Stage Pancreatic Cancer in a High-Risk Population, Across 2 Independent Clinical Validation Studies
The American Journal of Gastroenterology·2025
Abstract B094: Ketogenic Diet Modulates Gut Microbiome Composition and Enhances Treatment Response in Patients with Advanced Pancreatic Cancer: A Phase II Study
Cancer Research·2025
Abstract A098: Single nuclear profiling reveals type I IFN-mediated immune remodeling in platinum-refractory HRD-mutant PDAC responsive to checkpoint immunotherapy
Cancer Research·2025
Abstract B062: Extracellular vesicle based ALPPL2 and THBS2 as biomarkers for disease monitoring in pancreatic cancer patients undergoing neoadjuvant therapy
Cancer Research·2025
Abstract A068: A phase 2 study to investigate the efficacy and safety of acoustic cluster therapy with modified FOLFIRINOX in patients with locally advanced pancreatic cancer
Cancer Research·2025
Exosomal ALPPL2 and THBS2 as biomarkers for early detection and disease monitoring of pancreatic ductal adenocarcinoma
British Journal of Cancer·2025· 1 citedOpen Access
Adult pancreatoblastoma: Systematic review of the literature and case report of a young adult patient
World Journal of Gastrointestinal Oncology·2025Open Access
A Randomized Phase II Trial of Gemcitabine, Nab-Paclitaxel, Cisplatin with or without a Medically Supervised Ketogenic Diet for Patients with Metastatic Pancreatic Cancer
2025· 2 citedOpen Access
Biomarkers of response to immunotherapy in pancreatic ductal adenocarcinoma (PDAC) with homologous recombination deficiency (HRD).
Journal of Clinical Oncology·2025· 1 cited
An open-label, phase 1 trial with expansion cohort of botensilimab (AGEN1181) + balstilimab (AGEN2034) + nab-paclitaxel + gemcitabine + cisplatin + chloroquine + celecoxib in adult patients with previously untreated metastatic pancreatic cancer.
Journal of Clinical Oncology·2025
Phase 1 expansion study of FF-10832 (liposomal gemcitabine) antitumor activity in patients with advanced biliary carcinomas.
Journal of Clinical Oncology·2025
806: CLINICAL VALIDATION OF A NOVEL BLOOD-BASED MULTI-BIOMARKER TEST FOR THE EARLY DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA (PDAC) IN AN INDEPENDENT HIGH-RISK POPULATION SHOWS SIMILAR HIGH PERFORMANCE AS OBSERVED IN ITS MODEL DEVELOPMENT STUDY
Gastroenterology·2025
page 1 of 16Next →

Frequent Co-authors

Daniel D. Von Hoff(21), Gayle Jameson(8), Ronald L. Korn(7), Ramesh K. Ramanathan(5), Teresa Macarulla(4), Joon Oh Park(4), Haiyong Han(4), Gerald S. Falchook(4), Manish R. Patel(4), William McCulloch(4), George Kemble(4), Hani M. Babiker(4), Karen Ansaldo(4), Adi Diab(4), Bruno Bockorny(3), Valerya Semenisty(3), Mitesh J. Borad(3), David Gutiérrez Abad(3), Jaime Feliú(3), Amnon Peled(3)